Screening Tests Package at Chughtai Lab

Screening Tests Package at Chughtai Lab

Preventive healthcare is the cornerstone of modern medicine, shifting the clinical focus from treating established illnesses to detecting physiological imbalances before clinical symptoms manifest. The Screening Tests Package at Chughtai Lab is a comprehensive diagnostic panel designed to evaluate the functional status of vital organ systems, assess metabolic health, and identify early risk factors for chronic diseases. Headquartered in Lahore, Pakistan, with an extensive network of diagnostic centers nationwide, Chughtai Lab utilizes state-of-the-art automated laboratory technology to deliver highly accurate, reproducible, and clinically actionable results.

This screening package integrates multiple laboratory disciplines, including hematology, clinical chemistry, endocrinology, and urinalysis. By analyzing key biomarkers in the blood and urine, the panel provides a detailed physiological overview of the hematopoietic system, renal clearance, hepatic function, lipid metabolism, glycemic control, and thyroid activity. Early detection through routine screening is clinically proven to reduce morbidity and mortality associated with cardiovascular disease, Type 2 diabetes mellitus, chronic kidney disease, and hepatobiliary disorders. For patients across Pakistan, this package serves as an essential tool for proactive health management, enabling clinicians to design personalized preventive or therapeutic interventions.

Clinical Procedure: What to Expect

Patient Preparation

To ensure the clinical accuracy and reliability of the biomarker measurements, patients must adhere strictly to the following preparation guidelines:

• Fasting Requirements: A strict overnight fast of 10 to 12 hours is mandatory before sample collection. During this fasting period, the patient must not consume any food, caloric beverages, juices, tea, or coffee. Fasting is critical for obtaining accurate baseline measurements of Fasting Blood Sugar (FBS) and the Lipid Profile (including triglycerides, which are highly sensitive to recent dietary intake).
• Hydration: Patients are encouraged to drink plain water during the fasting period. Adequate hydration prevents hemoconcentration, ensures stable blood volume, and facilitates easier venipuncture.
• Medication Management: Routine medications should generally be taken as prescribed unless otherwise directed by the referring physician. However, patients must inform the laboratory staff of all prescription drugs, over-the-counter medications, and dietary supplements they are currently taking, as certain substances can interfere with enzymatic assays and hormone measurements.
• Avoidance of Alcohol and Vigorous Exercise: Patients should refrain from consuming alcohol and engaging in strenuous physical activity for at least 24 hours prior to the test, as these can temporarily alter liver enzyme levels, lipid fractions, and renal biomarkers.

During the Procedure

The collection of biological specimens for the Screening Tests Package at Chughtai Lab follows strict international safety and quality protocols to ensure patient comfort and sample integrity:

• Patient Identification and Verification: Upon arrival at the Chughtai Lab collection center, the phlebotomist verifies the patient’s identity using multiple identifiers and confirms compliance with the fasting instructions.
• Venipuncture Process: The patient is seated comfortably. The phlebotomist identifies a suitable vein, typically the median cubital vein in the antecubital fossa. The area is thoroughly sanitized using an antiseptic swab (70% isopropyl alcohol) and allowed to air dry.
• Sample Collection: A sterile, single-use vacuum tube system (Vacutainer) is used to draw the required volume of blood. Multiple tubes with specific anticoagulants or clot activators are filled in a precise order of draw to prevent cross-contamination of additives. This typically includes an EDTA tube for hematology, a sodium fluoride tube for glucose, and a serum separator tube (SST) for chemistry and endocrine assays.
• Urine Specimen Collection: The patient is provided with a sterile, leak-proof container and instructed on how to collect a mid-stream clean-catch urine specimen. This technique minimizes contamination from external urethral flora, ensuring an accurate urinalysis.
• Post-Collection Care: After removing the needle, gentle pressure is applied to the venipuncture site with a sterile cotton ball, followed by the application of a bandage. The patient is advised to keep the bandage on for at least 1 to 2 hours and avoid heavy lifting with that arm. The entire blood collection process is virtually painless, causing only a mild, brief pinching sensation, and is completed in less than five minutes.

When is a Screening Tests Package Performed?

Routine Annual Health Evaluation

Physicians recommend the Screening Tests Package as part of an annual wellness exam for asymptomatic individuals. This proactive approach establishes a baseline for key physiological markers, allowing clinicians to track subtle variations over time. Detecting subclinical deviations from normal ranges enables early lifestyle modifications or medical interventions, preventing the progression of silent diseases such as hypertension, early-stage renal decline, or metabolic syndrome.

Unexplained Fatigue and Lethargy

Persistent fatigue, generalized weakness, and diminished physical stamina are common clinical presentations that warrant comprehensive laboratory investigation. These non-specific symptoms can stem from various underlying etiologies, including microcytic or macrocytic anemia, subclinical hypothyroidism, chronic systemic inflammation, or electrolyte imbalances. The screening panel evaluates hemoglobin levels, red blood cell indices, and thyroid-stimulating hormone (TSH) to systematically rule out or diagnose these conditions.

Assessment of Cardiovascular Risk Factors

Cardiovascular diseases remain a leading cause of morbidity globally and in Pakistan. Clinicians frequently order this screening package for individuals with a family history of premature coronary artery disease, stroke, or myocardial infarction. By evaluating the complete lipid profile—including total cholesterol, low-density lipoprotein (LDL), high-density lipoprotein (HDL), and triglycerides—the panel provides essential data for calculating atherosclerotic cardiovascular disease (ASCVD) risk scores and guiding lipid-lowering therapies.

Monitoring Metabolic Health and Blood Sugar

With the rising prevalence of metabolic disorders, screening for impaired fasting glucose (IFG) and insulin resistance is vital. This package is indicated for individuals with risk factors such as obesity, sedentary lifestyle, gestational diabetes history, or a family history of Type 2 diabetes. Identifying prediabetic states through fasting blood glucose measurements allows patients to implement dietary and exercise interventions that can successfully reverse metabolic dysfunction before irreversible pancreatic beta-cell exhaustion occurs.

Evaluation of Renal and Hepatic Function

The liver and kidneys are the primary organs responsible for metabolism, detoxification, and waste excretion. Silent damage to these organs can occur due to non-alcoholic fatty liver disease (NAFLD), chronic viral hepatitis, medication-induced hepatotoxicity, or early-stage diabetic nephropathy. This screening package evaluates serum creatinine, urea, and key hepatic enzymes (such as ALT and AST), allowing physicians to detect early parenchymal damage or functional impairment before clinical signs like jaundice, fluid retention, or uremia develop.

What Does a Screening Tests Package Detect?

The Screening Tests Package at Chughtai Lab is highly comprehensive, evaluating multiple physiological pathways to detect a wide range of subclinical and clinical conditions. The diagnostic panel is capable of identifying the following findings:

• Anemia: Detected through reduced hemoglobin levels, low hematocrit, and altered red blood cell indices (MCV, MCH, MCHC), indicating iron deficiency, vitamin B12/folate deficiency, or chronic disease anemia.
• Infections and Inflammatory States: Indicated by elevated white blood cell (WBC) counts or abnormalities in the differential leukocyte count.
• Thrombocytopenia or Thrombocytosis: Identified via abnormal platelet counts, which can affect blood clotting mechanisms.
• Hyperglycemia and Prediabetes: Indicated by elevated fasting blood glucose levels, pointing toward impaired glucose tolerance or undiagnosed Type 2 diabetes mellitus.
• Hypoglycemia: Abnormally low fasting blood glucose levels, which may suggest endocrine disorders or metabolic imbalances.
• Hypercholesterolemia: Elevated total cholesterol levels, a primary risk factor for atherosclerosis.
• Atherogenic Dyslipidemia: Characterized by elevated low-density lipoprotein (LDL-C) and triglycerides, combined with low high-density lipoprotein (HDL-C) levels.
• Impaired Renal Clearance: Indicated by elevated serum creatinine and blood urea nitrogen (BUN) levels, suggesting compromised glomerular filtration.
• Hyperuricemia: Elevated serum uric acid levels, which can lead to gouty arthritis or renal calculi.
• Hepatocellular Injury: Indicated by elevated alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels, reflecting liver cell inflammation or damage.
• Cholestasis: Suggested by elevated alkaline phosphatase (ALP) and bilirubin levels, indicating biliary tract obstruction or dysfunction.
• Hypoproteinemia: Reduced serum total protein or albumin levels, pointing toward nutritional deficiencies, malabsorption, liver disease, or protein-losing nephropathy.
• Primary Hypothyroidism: Characterized by elevated Thyroid Stimulating Hormone (TSH) levels, indicating underactive thyroid function.
• Hyperthyroidism: Indicated by abnormally suppressed TSH levels, suggesting excess thyroid hormone production.
• Urinary Tract Infection (UTI): Detected via the presence of leukocytes, nitrites, and bacteria in the urine routine examination.
• Microhematuria: The presence of microscopic red blood cells in the urine, which may indicate renal calculi, infection, or urothelial pathology.
• Proteinuria: The excretion of protein in the urine, an early marker of glomerular damage and diabetic nephropathy.
• Glucosuria: The presence of glucose in the urine, occurring when blood glucose levels exceed the renal threshold.
• Ketonuria: The presence of ketone bodies in the urine, indicating altered metabolic states such as diabetic ketoacidosis or prolonged fasting.
• Bilirubinuria: The presence of conjugated bilirubin in the urine, suggesting hepatobiliary disease or biliary obstruction.

Turnaround Time and Report Access at Chughtai Lab

Chughtai Lab is widely recognized across Pakistan for its highly efficient laboratory workflow and rapid reporting timelines. For the Screening Tests Package, specimen processing begins immediately upon receipt at the laboratory. Utilizing advanced, high-throughput automated analyzers integrated with a secure Laboratory Information Management System (LIMS), Chughtai Lab minimizes human error and expedites verification processes.

The final, verified diagnostic reports are typically available within 12 to 24 hours of sample collection. Patients and referring physicians are notified via SMS once the results are finalized. Reports can be accessed and downloaded digitally through multiple convenient channels, including the official Chughtai Lab website portal, the dedicated Chughtai Lab mobile application, and via their automated WhatsApp service. Physical copies of the reports can also be collected from any Chughtai Lab diagnostic center or home delivery can be requested, ensuring seamless access to critical health data.

Screening Tests Package Findings Overview

Structure / Parameter Evaluated	Normal Findings	Possible Abnormal Findings
Complete Blood Count (CBC)	Normal Hemoglobin, WBC, and Platelet counts within age-specific reference ranges.	Anemia (low Hb), Leukocytosis (high WBC indicating infection), Thrombocytopenia (low platelets).
Fasting Blood Glucose (FBG)	70 to 99 mg/dL (Normal glycemic control).	100 to 125 mg/dL (Prediabetes); ≥ 126 mg/dL (Suspected Diabetes Mellitus).
Lipid Profile (Total Cholesterol, LDL, HDL, Triglycerides)	Optimal lipid fractions (e.g., LDL < 100 mg/dL, Triglycerides < 150 mg/dL).	Hypercholesterolemia, elevated LDL-C, hypertriglyceridemia, low HDL-C (increased cardiovascular risk).
Renal Function (Serum Creatinine & Urea)	Creatinine and Urea within normal physiological ranges, indicating adequate glomerular filtration.	Elevated Creatinine and Urea, indicating acute kidney injury (AKI) or chronic kidney disease (CKD).
Liver Function Tests (ALT, AST, ALP, Bilirubin)	Normal hepatic enzyme activity and bilirubin levels, indicating healthy hepatocytes and biliary flow.	Elevated ALT/AST (hepatocellular damage), elevated ALP/Bilirubin (cholestasis or biliary obstruction).
Thyroid Stimulating Hormone (TSH)	0.4 to 4.0 mIU/L (Euthyroid state).	Elevated TSH (Hypothyroidism); Suppressed TSH (Hyperthyroidism).
Urine Routine Examination (Urine RE)	Clear, straw-colored urine; negative for protein, glucose, ketones, nitrites, and significant red/white blood cells.	Proteinuria (renal damage), Glucosuria (diabetes), Pyuria/Bacteriuria (UTI), Hematuria (calculi or trauma).

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Chughtai Lab for Screening Tests Package?

• ISO 15189 Certified Processes: Chughtai Lab operates in compliance with international quality standards, ensuring rigorous quality control and highly accurate diagnostic results.
• Experienced Pathologists and Scientists: All laboratory investigations are supervised, reviewed, and signed off by highly qualified consultant pathologists and clinical scientists.
• State-of-the-Art Automated Technology: The laboratory utilizes advanced, high-throughput automated analyzers from leading global diagnostic manufacturers, reducing manual handling and analytical errors.
• Extensive Nationwide Network: With hundreds of collection centers across Lahore and throughout Pakistan, patients can easily access diagnostic services close to home.
• Convenient Home Sampling Services: Chughtai Lab offers professional, sterile home sample collection services, allowing patients to undergo screening in the comfort of their homes.
• Rapid Turnaround Time: Efficient laboratory workflows ensure that comprehensive screening reports are processed, verified, and delivered within 12 to 24 hours.
• Seamless Digital Report Access: Patients can easily view, download, and share their diagnostic reports via the Chughtai Lab website, mobile app, or WhatsApp.
• Patient-Focused Care and Comfort: From highly trained phlebotomists to comfortable, hygienic collection environments, patient well-being is prioritized at every step of the diagnostic journey.